![Western Blot: AIPL1 Antibody (3B4) [NBP2-01327] Analysis of extracts (35ug) from 9 different cell lines by using anti-AIPL1 monoclonal antibody.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Western-Blot-NBP2-01327-img0007.jpg "Western Blot: AIPL1 Antibody (3B4) [NBP2-01327] Analysis of extracts (35ug) from 9 different cell lines by using anti-AIPL1 monoclonal antibody.")
| Reactivity | Hu, Mu, RtSpecies Glossary |
| Applications | WB, Flow, ICC/IF, IHC |
| Clone | OTI3B4 |
| Clonality | Monoclonal |
| Host | Mouse |
| Conjugate | Unconjugated |
| Concentration | 1 mg/ml |
| Immunogen | Full length human recombinant protein of human AIPL1(NP_055151) produced in HEK293T cell. |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Host | Mouse |
| Gene | AIPL1 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Theoretical MW | 43.7 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.3), 1.0% BSA and 50% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Concentration | 1 mg/ml |
| Purity | Immunogen affinity purified |
Secondary Antibodies |
Isotype Controls |
Research Areas for AIPL1 Antibody (NBP2-01327)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunocytochemistry/Immunofluorescence: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Immunocytochemistry-Immunofluorescence-NBP2-01327-img0006.jpg "Immunocytochemistry/Immunofluorescence: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1.")
![Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Human pancreas tissue using anti-AIPL1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Immunohistochemistry-Paraffin-NBP2-01327-img0005.jpg "Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Human pancreas tissue using anti-AIPL1 mouse monoclonal antibody.")
![Flow Cytometry: AIPL1 Antibody (3B4) [NBP2-01327] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-AIPL1 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Flow-Cytometry-NBP2-01327-img0001.jpg "Flow Cytometry: AIPL1 Antibody (3B4) [NBP2-01327] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-AIPL1 antibody, and then analyzed by flow cytometry.")
![Western Blot: AIPL1 Antibody (3B4) [NBP2-01327] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Western-Blot-NBP2-01327-img0002.jpg "Western Blot: AIPL1 Antibody (3B4) [NBP2-01327] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.")
![Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-AIPL1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Immunohistochemistry-Paraffin-NBP2-01327-img0003.jpg "Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-AIPL1 mouse monoclonal antibody.")
![Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Human lymph node tissue using anti-AIPL1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/AIPL1-Antibody-3B4-Immunohistochemistry-Paraffin-NBP2-01327-img0004.jpg "Immunohistochemistry-Paraffin: AIPL1 Antibody (3B4) [NBP2-01327] - Staining of paraffin-embedded Human lymph node tissue using anti-AIPL1 mouse monoclonal antibody.")
![Immunohistochemistry CD45 Antibody [Unconjugated]](https://images.novusbio.com/images2/CD45_AF114_Immunohistochemistry_23525.jpg)
![Immunocytochemistry CD45 Antibody [Unconjugated]](https://images.novusbio.com/images2/af114_mouse-cd45-affinity-purified-polyclonal-ab-immunocytochemistry-6122021145449.jpg)
![Immunocytochemistry/ Immunofluorescence CD45 Antibody [Unconjugated]](https://images.novusbio.com/images/af114_mouse-cd45-affinity-purified-polyclonal-ab-41202410331954.jpg)
![Flow Cytometry Mer Antibody [Unconjugated]](https://images.novusbio.com/images2/Mer_AF591_Flow_Cytometry_12100.jpg)
![Immunohistochemistry Mer Antibody [Unconjugated]](https://images.novusbio.com/images2/Mer_AF591_Immunohistochemistry_22755.jpg)
![Dual RNAscope ISH-IHC Compatible Mer Antibody [Unconjugated]](https://images.novusbio.com/images2/Mer_AF591_Dual_RNAscope_ISHIHC_23834.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")